Nrf2 Overexpression Predicts Prognosis and 5-FU Resistance in Gastric Cancer

Hu, Xiu-Feng; Yao, Jun; Gao, She-Gan; Wang, Xin-Shuai; Peng, Xiu-Qing; Yang, Yan-Tong; Feng, Xiao-Shan

추천

검색

자료유형: 학술저널

저자정보: Hu, Xiu-Feng (Department of Oncology, Cancer Research Institute, the First Affiliated Hospital of Henan University of Science and Technology) Yao, Jun (Department of Oncology, Cancer Research Institute, the First Affiliated Hospital of Henan University of Science and Technology) Gao, She-Gan (Department of Oncology, Cancer Research Institute, the First Affiliated Hospital of Henan University of Science and Technology) Wang, Xin-Shuai (Department of Oncology, Cancer Research Institute, the First Affiliated Hospital of Henan University of Science and Technology) Peng, Xiu-Qing (Department of Oncology, Cancer Research Institute, the First Affiliated Hospital of Henan University of Science and Technology) Yang, Yan-Tong (Department of Oncology, Cancer Research Institute, the First Affiliated Hospital of Henan University of Science and Technology) Feng, Xiao-Shan (Department of Oncology, Cancer Research Institute, the First Affiliated Hospital of Henan University of Science and Technology)

저널정보: 아시아태평양암예방학회 Asian Pacific journal of cancer prevention : APJCP Asian Pacific journal of cancer prevention : APJCP 제14권 제9호

발행연도: 2013.1

수록면: 5,231 - 5,235 (5page)

이용수

📌

연구주제

📖

연구배경

🔬

연구방법

🏆

연구결과

초록· 키워드

오류제보하기

Objective: NF-E2-related factor 2 (Nrf2) is activated in several human malignancies. However, the role of Nrf2 in gastric cancer (GC) remains incompletely understood. In this study, we therefore analyzed associations of Nrf2 expression status with clinical features and chemotherapeutic resistance in GC. Materials and Methods: A total of 186 samples from GC patients who underwent gastrectomy were used for prognostic assessment. A further 142 samples from GC cases who received first-line combination chemotherapy were applied for investigation of chemoresistance. The Nrf2 expression was evaluated by immunohistochemistry in GC samples, and its relationship with clinicopathological parameters and chemotherapy sensitivity was analyzed. The effect of Nrf2 gene silencing on chemotherapy resistance was also examined by cell viability assay in vivo. Results: Of the 186 patients with GC, 104/186 (55.9%) showed high expression for Nrf2. The overexpression of Nrf2 was an independent predictor of overall survival [OS, hazard ratio (HR) 3.9; P=0.011] and disease-free survival (DFS, HR 4.3; P=0.002). The gene silencing of Nrf2 reduced resistance to cell death induced by 5-FU in GC cell lines. Conclusion: Our data show that Nrf2 is an independent prognostic factor in GC. Furthermore, Nrf2 confers resistance to chemotherapeutic drug 5-FU in GC cells. Taken together, Nrf2 is a potential prognostic marker and predictive for 5-FU resistance in GC.

#Gastric cancer #Nrf2 #drug resistance #prognosis

참고문헌 (0)

참고문헌 신청

참고문헌이 DBpia에서 서비스 중이라면, [참고문헌 신청]을 통해 등록해보세요

이 논문의 저자 정보

Hu, Xiu-Feng

소속기관 Department of Oncology, Cancer Research Institute, the First Affiliated Hospital of Henan University